Arcturus Therapeutics Holdings Inc (ARCT) support and resistance · rev $152.3M
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
This page maps Arcturus Therapeutics Holdings Inc (ARCT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ARCT revenue for 2024-12-31 was $152.3M. Net income was -$80.9M. Revenue was down 8.7% from 2023-12-31 to 2024-12-31. ARCT currently screens at market cap $369.4M.
ARCT currently screens at market cap $369.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ARCT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ARCT quote page for the session range and the stock page for the full model.
Not investment advice.